Stoke Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Stoke Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Stoke Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -57.9 %, a 9.35% decline year-over-year.
  • Stoke Therapeutics, Inc. annual Return On Equity for 2023 was -56.9 %, a 20% decline from 2022.
  • Stoke Therapeutics, Inc. annual Return On Equity for 2022 was -47.4 %, a 35.7% decline from 2021.
  • Stoke Therapeutics, Inc. annual Return On Equity for 2021 was -34.9 %, a 49.8% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -56.9 -9.48 -20% Jan 1, 2023 Dec 31, 2023
2022 -47.4 -12.5 -35.7% Jan 1, 2022 Dec 31, 2022
2021 -34.9 -11.6 -49.8% Jan 1, 2021 Dec 31, 2021
2020 -23.3 -7.14 -44.1% Jan 1, 2020 Dec 31, 2020
2019 -16.2 +18.1 +52.9% Jan 1, 2019 Dec 31, 2019
2018 -34.3 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.